136 related articles for article (PubMed ID: 12527132)
1. Otoacoustic emissions and brainstem evoked potentials in compound carriers of connexin 26 mutations.
Engel-Yeger B; Zaaroura S; Zlotogora J; Shalev S; Hujeirat Y; Carrasquillo M; Saleh B; Pratt H
Hear Res; 2003 Jan; 175(1-2):140-51. PubMed ID: 12527132
[TBL] [Abstract][Full Text] [Related]
2. The effects of a connexin 26 mutation--35delG--on oto-acoustic emissions and brainstem evoked potentials: homozygotes and carriers.
Engel-Yeger B; Zaaroura S; Zlotogora J; Shalev S; Hujeirat Y; Carrasquillo M; Barges S; Pratt H
Hear Res; 2002 Jan; 163(1-2):93-100. PubMed ID: 11788203
[TBL] [Abstract][Full Text] [Related]
3. Audiological and electrocochleography findings in hearing-impaired children with connexin 26 mutations and otoacoustic emissions.
Santarelli R; Cama E; Scimemi P; Dal Monte E; Genovese E; Arslan E
Eur Arch Otorhinolaryngol; 2008 Jan; 265(1):43-51. PubMed ID: 17701047
[TBL] [Abstract][Full Text] [Related]
4. Abnormal cochlear potentials from deaf patients with mutations in the otoferlin gene.
Santarelli R; Del Castillo I; Rodríguez-Ballesteros M; Scimemi P; Cama E; Arslan E; Starr A
J Assoc Res Otolaryngol; 2009 Dec; 10(4):545-56. PubMed ID: 19636622
[TBL] [Abstract][Full Text] [Related]
5. Connexin 26 and connexin 30 mutations in children with nonsyndromic hearing loss.
Erbe CB; Harris KC; Runge-Samuelson CL; Flanary VA; Wackym PA
Laryngoscope; 2004 Apr; 114(4):607-11. PubMed ID: 15064611
[TBL] [Abstract][Full Text] [Related]
6. Hearing function in heterozygous carriers of a pathogenic GJB2 gene mutation.
Groh D; Seeman P; Jilek M; Popelář J; Kabelka Z; Syka J
Physiol Res; 2013; 62(3):323-30. PubMed ID: 23489192
[TBL] [Abstract][Full Text] [Related]
7. Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1).
Cohn ES; Kelley PM; Fowler TW; Gorga MP; Lefkowitz DM; Kuehn HJ; Schaefer GB; Gobar LS; Hahn FJ; Harris DJ; Kimberling WJ
Pediatrics; 1999 Mar; 103(3):546-50. PubMed ID: 10049954
[TBL] [Abstract][Full Text] [Related]
8. Connexin 26 variants and auditory neuropathy/dys-synchrony among children in schools for the deaf.
Cheng X; Li L; Brashears S; Morlet T; Ng SS; Berlin C; Hood L; Keats B
Am J Med Genet A; 2005 Nov; 139(1):13-8. PubMed ID: 16222667
[TBL] [Abstract][Full Text] [Related]
9. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
Hoth S
Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
[TBL] [Abstract][Full Text] [Related]
10. A novel connexin 26 compound heterozygous mutation results in deafness.
Harris KC; Erbe CB; Firszt JB; Flanary VA; Wackym PA
Laryngoscope; 2002 Jul; 112(7 Pt 1):1159-62. PubMed ID: 12169891
[TBL] [Abstract][Full Text] [Related]
11. Temporal bone histopathology in connexin 26-related hearing loss.
Jun AI; McGuirt WT; Hinojosa R; Green GE; Fischel-Ghodsian N; Smith RJ
Laryngoscope; 2000 Feb; 110(2 Pt 1):269-75. PubMed ID: 10680928
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of salicylate, quinine, and furosemide on Guinea pig inner and outer hair cell function revealed by the input-output relation of the auditory brainstem response.
Pienkowski M; Ulfendahl M
J Am Acad Audiol; 2011 Feb; 22(2):104-12. PubMed ID: 21463565
[TBL] [Abstract][Full Text] [Related]
13. [Otoacoustic emissions, auditory evoked potentials, pure tone thresholds and speech intelligibility in cases of auditory neuropathy].
Ptok M
HNO; 2000 Jan; 48(1):28-32. PubMed ID: 10663046
[TBL] [Abstract][Full Text] [Related]
14. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Dinopoulou D; Vossinakis I; Tsakanikos M; Douniadakis D
Int J Pediatr Otorhinolaryngol; 1999 Nov; 50(3):177-84. PubMed ID: 10595663
[TBL] [Abstract][Full Text] [Related]
15. Deterioration in Distortion Product Otoacoustic Emissions in Auditory Neuropathy Patients With Distinct Clinical and Genetic Backgrounds.
Kitao K; Mutai H; Namba K; Morimoto N; Nakano A; Arimoto Y; Sugiuchi T; Masuda S; Okamoto Y; Morita N; Sakamoto H; Shintani T; Fukuda S; Kaga K; Matsunaga T
Ear Hear; 2019; 40(1):184-191. PubMed ID: 29688962
[TBL] [Abstract][Full Text] [Related]
16. Does universal newborn hearing screening identify all children with GJB2 (Connexin 26) deafness? Penetrance of GJB2 deafness.
Norris VW; Arnos KS; Hanks WD; Xia X; Nance WE; Pandya A
Ear Hear; 2006 Dec; 27(6):732-41. PubMed ID: 17086082
[TBL] [Abstract][Full Text] [Related]
17. Audiological features of GJB2 (connexin 26) deafness.
Liu XZ; Pandya A; Angeli S; Telischi FF; Arnos KS; Nance WE; Balkany T
Ear Hear; 2005 Jun; 26(3):361-9. PubMed ID: 15937416
[TBL] [Abstract][Full Text] [Related]
18. Connexin 26 mutations in nonsyndromic autosomal recessive hearing loss: speech and hearing rehabilitation.
Mesolella M; Tranchino G; Nardone M; Motta S; Galli V
Int J Pediatr Otorhinolaryngol; 2004 Aug; 68(8):995-1005. PubMed ID: 15236885
[TBL] [Abstract][Full Text] [Related]
19. Distortion product otoacoustic emissions and outer hair cell defects in the hyt/hyt mutant mouse.
Li D; Henley CM; O'Malley BW
Hear Res; 1999 Dec; 138(1-2):65-72. PubMed ID: 10575115
[TBL] [Abstract][Full Text] [Related]
20. Cx26 deafness: mutation analysis and clinical variability.
Murgia A; Orzan E; Polli R; Martella M; Vinanzi C; Leonardi E; Arslan E; Zacchello F
J Med Genet; 1999 Nov; 36(11):829-32. PubMed ID: 10544226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
